Tuberculosis
January/February 2023: A 24-week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
Article and Study Summary: A 24-week, All-Oral Regimen for Rifampin-Resistant Tuberculosis Published in: N Engl J Med. 2022;387(25):2331-2343. https://www.nejm.org/doi/full/10.1056/NEJMoa2117166 Authors: Nyang’wa B, Berry C, Kazounis E, et al. Summary This...Reasons for poor uptake of TB preventive therapy in South Africa
Authors: D P Baloyi, M G Anthony, K A Meyerson, S Mazibuko, D Wademan, L Viljoen, H Myburgh, K du Preez, M Osman, Y Hirsch-Moverman, S Charalambous, H Hausler, A C Hesseling, G Hoddinott Abstract: Background: South Africa has one the highest TB and HIV burdens...Effectiveness of a Community-based Intervention to Prevent Childhood TB in Lesotho
Abstract: BACKGROUND: Child contact management (CCM) is a recognized strategy to prevent TB; however, implementation is suboptimal. PREVENT was a cluster-randomized trial that evaluated the effectiveness and acceptability of a community-based intervention (CBI) to...
